Titel

Merkliste
1 Ergebnisse

A randomized controlled trial of OPT-302, a VEGF-C/D inhibi..:

Jackson, Timothy L ; Slakter, Jason ; Buyse, Marc...
Jackson , T L , Slakter , J , Buyse , M , Wang , K , Dugel , P U , Wykoff , C C , Boyer , D S , Gerometta , M , Baldwin , M E & Price , C F 2023 , ' A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration ' , Ophthalmology . https://doi.org/10.1016/j.ophtha.2023.02.001. , 2023

Link: https://kclpure.kcl.ac.uk/portal/en/publications/a-ran..

RT Journal
T1 <Title>A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftkingscollondon:oai:pure.atira.dk:publications_f63ccbd2-ef0e-4254-90c2-8743aaf44df3&Exemplar=1&LAN=DE
				
A1 Jackson, Timothy L
A1 Slakter, Jason
A1 Buyse, Marc
A1 Wang, Kun
A1 Dugel, Pravin U
A1 Wykoff, Charles C
A1 Boyer, David S
A1 Gerometta, Michael
A1 Baldwin, Megan E
A1 Price, Clare F
YR 2023
JF Jackson , T L , Slakter , J , Buyse , M , Wang , K , Dugel , P U , Wykoff , C C , Boyer , D S , Gerometta , M , Baldwin , M E & Price , C F 2023 , ' A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration ' , Ophthalmology . https://doi.org/10.1016/j.ophtha.2023.02.001
LK http://dx.doi.org/https://kclpure.kcl.ac.uk/portal/en/publications/a-randomized-controlled-trial-of-opt302-a-vegfcd-inhibitor-for-neovascular-agerelated-macular-degeneration(f63ccbd2-ef0e-4254-90c2-8743aaf44df3).html
DO https://kclpure.kcl.ac.uk/portal/en/publications/a-randomized-controlled-trial-of-opt302-a-vegfcd-inhibitor-for-neovascular-agerelated-macular-degeneration(f63ccbd2-ef0e-4254-90c2-8743aaf44df3).html
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)